Study on cancer in the upper urinary tract
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial is for people diagnosed with a rare type of cancer in the upper urinary tract (UTUC). Researchers hope to learn more about this condition and find better ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer in the lining of the upper urinary tract (UTUC).
- You are 18 years old or older.
- You are willing and able to give informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches people with upper tract urothelial cancer who are having surgery to remove the kidney and ureter. It aims to collect information to better understand the disease and improve future care.
This trial tests a combination of an oral targeted drug (DV) and an immunotherapy (Toripalimab) to preserve kidney function in people with high-risk upper tract urothelial cancer (UTUC) who cannot have their kidney and ureter removed. It is for patients with only one kidney, reduced kidney function, or cancer in both ureters.
This trial tests a new treatment called UGN-104 for people with low-grade upper tract urothelial cancer (a type of cancer in the tube that carries urine from the kidney to the bladder). The treatment is given directly into the kidney area to kill cancer cells without surgery.
This study looks at how well patients do when they have kidney-sparing treatment (instead of complete kidney removal) for upper tract urothelial carcinoma. It helps doctors understand which patients can safely avoid losing their kidney.
This study looks at what happens in and around the time of surgery for upper tract urothelial cancer. It may help doctors better understand how the disease and the body respond to treatment.
This trial is testing a system that helps doctors choose the best additional treatment for people with advanced upper tract urothelial cancer (UTUC) after their surgery. It focuses on patients whose cancer has spread into the muscle layer or beyond, or to nearby lymph nodes.
Hear when a new Upper Urinary Tract Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.